Alnylam Pharmaceuticals
ALNY
#650
Rank
C$43.51 B
Marketcap
$337.41
Share price
-7.14%
Change (1 day)
44.89%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Cash on Hand

Cash on Hand as of September 2024 : C$3.91 Billion

According to Alnylam Pharmaceuticals 's latest financial reports the company has C$3.91 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Alnylam Pharmaceuticals - Cash on Hand chart (from 2003 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31C$3.23 B8.76%
2022-12-31C$2.97 B-4.16%
2021-12-31C$3.10 B29.87%
2020-12-31C$2.38 B19.12%
2019-12-31C$2.00 B35.85%
2018-12-31C$1.47 B-30.52%
2017-12-31C$2.12 B152.34%
2016-12-31C$0.84 B-43.8%
2015-12-31C$1.49 B85.4%
2014-12-31C$0.80 B208.91%
2013-12-31C$0.26 B114.31%
2012-12-31C$0.12 B-17.99%
2011-12-31C$0.14 B-36.1%
2010-12-31C$0.23 B-21.3%
2009-12-31C$0.29 B-43.42%
2008-12-31C$0.52 B34.52%
2007-12-31C$0.38 B53.79%
2006-12-31C$0.25 B171.58%
2005-12-31C$93.14 M68.41%
2004-12-31C$55.3 M83.83%
2003-12-31C$30.08 M23.08%
2002-12-31C$24.44 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$0.61 B-84.37%๐Ÿ‡บ๐Ÿ‡ธ USA
C$13.80 B 252.36%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.68 B-56.90%๐Ÿ‡บ๐Ÿ‡ธ USA
C$57.16 M-98.54%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.13 B-96.60%๐Ÿ‡บ๐Ÿ‡ธ USA
C$19.75 B 404.27%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
C$10.26 B 162.00%๐Ÿ‡ซ๐Ÿ‡ท France
C$4.67 B 19.38%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel